Nexgel Inc NXGL

$0.26 -0.01 (-3.06%)

Valuation

Market cap
2,614,000
Revenue TTM
$11,420,000
Net income TTM
$-3,000,000
PE ratio
0.00
Forward PE
—
Profit margin
-26.27%
Debt to equity
0.00

Trading

Volume
334,000
Avg volume
796,318
Day's range
$0.25 – $0.28
Shares out
9,748,000
Stochastic %K
43%
Beta
0.76
Analysts
Hold
Price target
$2.00

Price

Company profile

NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States. It operates through two segments: Nexgel and CG labs. The company offers over-the-counter remedy solutions, such as blister and pain applications; and beauty and cosmetic solutions. It also develops NEXDrape...

Show more

NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States. It operates through two segments: Nexgel and CG labs. The company offers over-the-counter remedy solutions, such as blister and pain applications; and beauty and cosmetic solutions. It also develops NEXDrape, an incise surgical drape designed for patients with impaired skin; and NEXDerm, an adhesive tape designed to secure central lines and intravenous tubes and devices to patients before, during, and after medical treatment. In addition, the company engages in the converting and packaging business. It serves its customers under Medagel, Kenkoderm and Silly George brand names. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was incorporated in 2009 and is based in Langhorne, Pennsylvania.

Industry
Medical Instruments & Supplies
Sector
Healthcare
Phone
215 702 8550
Website
https://nexgel.com
Address
2150 Cabot Boulevard West, Suite B, Langhorne, United States

Latest news

No headlines yet.